These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4089198)

  • 1. Brain adenylate cyclase activity in the amphetamine sensitized rat.
    Mamelak M; Chiu S; Mishra R
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):721-4. PubMed ID: 4089198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential down-regulation of D1-stimulated adenylate cyclase activity in rat forebrain after in vivo amphetamine treatments.
    Roberts-Lewis JM; Roseboom PH; Iwaniec LM; Gnegy ME
    J Neurosci; 1986 Aug; 6(8):2245-51. PubMed ID: 3018190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reductions in binding and functions of D2 dopamine receptors in the rat ventral striatum during amphetamine sensitization.
    Chen JC; Su HJ; Huang LI; Hsieh MM
    Life Sci; 1999; 64(5):343-54. PubMed ID: 10072194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forskolin potentiates the stimulation of rat striatal adenylate cyclase mediated by D-1 dopamine receptors, guanine nucleotides, and sodium fluoride.
    Battaglia G; Norman AB; Hess EJ; Creese I
    J Neurochem; 1986 Apr; 46(4):1180-5. PubMed ID: 3005508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of lithium in vitro and in vivo on dopamine-sensitive adenylate cyclase activity in dopaminergic areas of the rat brain.
    Geisler A; Klysner R
    Acta Pharmacol Toxicol (Copenh); 1985 Jan; 56(1):1-5. PubMed ID: 2983514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased sensitivity of adenylate cyclase activity in the striatum of the rat to calmodulin and GppNHp after chronic treatment with haloperidol.
    Treisman GJ; Muirhead N; Gnegy ME
    Neuropharmacology; 1986 Jun; 25(6):587-95. PubMed ID: 3092124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dopamine on activation of rat striatal adenylate cyclase by free Mg2+ and guanyl nucleotides.
    McSwigan JD; Nicol SE; Gottesman II; Tuason VB; Frey WH
    J Neurochem; 1980 Mar; 34(3):594-601. PubMed ID: 7354334
    [No Abstract]   [Full Text] [Related]  

  • 8. Selective adenylate cyclase increase in the limbic area of long-term imipramine-treated rats.
    De Montis GM; Devoto P; Gessa GL; Porcella A; Serra G; Tagliamonte A
    Eur J Pharmacol; 1990 May; 180(1):169-74. PubMed ID: 2194824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmortem stability of dopamine-sensitive adenylate cyclase, guanylate cyclase, ATPase, and GTPase in rat striatum.
    Nicol SE; Senogles SE; Caruso TP; Hudziak JJ; McSwigan JD; Frey WH
    J Neurochem; 1981 Dec; 37(6):1535-9. PubMed ID: 6120996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of thiol-protecting reagents on the size of solubilized adenylate cyclase and on its ability to be stimulated by guanyl nucleotides and fluoride.
    Guillon G; Cantau B; Jard S
    Eur J Biochem; 1981 Jul; 117(2):401-6. PubMed ID: 7274217
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of crosslinking agents on adenylate cyclase regulation.
    Monneron A; d'Alayer J
    FEBS Lett; 1980 Jan; 109(1):75-80. PubMed ID: 6766406
    [No Abstract]   [Full Text] [Related]  

  • 12. Factors affecting solubilized dopamine-sensitive adenylate cyclase.
    Marshall AM; Ramwani J; Mishra RK
    Biochem Pharmacol; 1983 Apr; 32(7):1237-41. PubMed ID: 6847713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desensitization of rat striatal dopamine-stimulated adenylate cyclase after acute amphetamine administration.
    Barnett JV; Kuczenski R
    J Pharmacol Exp Ther; 1986 Jun; 237(3):820-5. PubMed ID: 2940359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phorbol esters increase GTP-dependent adenylate cyclase activity in rat brain striatal membranes.
    Olianas MC; Onali P
    J Neurochem; 1986 Sep; 47(3):890-7. PubMed ID: 3734803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in beta-adrenergic stimulation of myocardial adenylate cyclase in endotoxic rats.
    Romano FD; Jones SB
    Am J Physiol; 1986 Mar; 250(3 Pt 2):R358-64. PubMed ID: 3006518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of substance P on guanine nucleotide--activated striatal adenylate cyclase.
    Moser A
    Ann N Y Acad Sci; 1991; 632():444-6. PubMed ID: 1719900
    [No Abstract]   [Full Text] [Related]  

  • 17. Adenylate cyclase system of the rat striatum: regulatory properties and the effects of gangliosides.
    Plesneva SA; Nalivaeva NN; Zhuravin IA
    Neurosci Behav Physiol; 1998; 28(4):392-6. PubMed ID: 9762710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of rat cardiac adenylate cyclase activity with age.
    Robberecht P; Gillard M; Waelbroeck M; Camus JC; De Neef P; Christophe J
    Eur J Pharmacol; 1986 Jul; 126(1-2):91-5. PubMed ID: 3758167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LSD and dopamine-sensitive adenylate-cyclase in various rat brain areas.
    Spano PF; Kumakura K; Tonon GC; Govoni S; Trabucchi M
    Brain Res; 1975 Jul; 93(1):164-7. PubMed ID: 166729
    [No Abstract]   [Full Text] [Related]  

  • 20. [Adenylate cyclase system of the striatum in rats: regulatory properties and effect of gangliosides].
    Plesneva SA; Nalivaeva NN; Zhuravin IA
    Ross Fiziol Zh Im I M Sechenova; 1997; 83(1-2):90-5. PubMed ID: 13676990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.